APO Research
Talk to an analyst

APO RESEARCH · REPORT

Icatibant Acetate Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Icatibant Acetate Injection Industry Growth and Trends Forecast to 2032

28 December 202595 pages

Choose your research edition.

Industry ResearchIcatibant Acetate Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Icatibant Acetate Injection Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Icatibant Acetate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Icatibant Acetate Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Icatibant Acetate Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Icatibant Acetate Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Icatibant Acetate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Icatibant Acetate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Icatibant Acetate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Icatibant Acetate Injection include Cipla, Eugia Pharma Specialities, Fresenius Kabi, Glenmark Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy, Jiangsu Hengrui Pharmaceuticals, Sandoz and Takeda Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Icatibant Acetate Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Icatibant Acetate Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Icatibant Acetate Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Icatibant Acetate Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Icatibant Acetate Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Icatibant Acetate Injection Market by Company

Cipla

Eugia Pharma Specialities

Fresenius Kabi

Glenmark Pharmaceuticals

Chengdu Shengnuo Biology Pharmacy

Jiangsu Hengrui Pharmaceuticals

Sandoz

Takeda Pharmaceuticals

Icatibant Acetate Injection Segment by Type

Original Drug

Generic Drug

Icatibant Acetate Injection Segment by Application

Hospital and Clinic

Pharmacy

Other

Icatibant Acetate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Icatibant Acetate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Icatibant Acetate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Icatibant Acetate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Icatibant Acetate Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Icatibant Acetate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Original Drug Table 2. Major Company of Generic Drug Table 3. Global Icatibant Acetate Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Icatibant Acetate Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Icatibant Acetate Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Icatibant Acetate Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Icatibant Acetate Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Icatibant Acetate Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Icatibant Acetate Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Icatibant Acetate Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Icatibant Acetate Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Icatibant Acetate Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Icatibant Acetate Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Icatibant Acetate Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Icatibant Acetate Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Icatibant Acetate Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Icatibant Acetate Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Icatibant Acetate Injection Industry Trends Table 25. Icatibant Acetate Injection Industry Drivers Table 26. Icatibant Acetate Injection Industry Opportunities and Challenges Table 27. Icatibant Acetate Injection Industry Restraints Table 28. Global Icatibant Acetate Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Icatibant Acetate Injection Revenue Market Share by Company (2021-2026) Table 30. Global Icatibant Acetate Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Icatibant Acetate Injection Sales Share by Company (2021-2026) Table 32. Global Icatibant Acetate Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Icatibant Acetate Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Icatibant Acetate Injection Major Company Production Sites and Headquarters Table 35. Global Icatibant Acetate Injection Company, Product Type & Application Table 36. Global Icatibant Acetate Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Icatibant Acetate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Icatibant Acetate Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Icatibant Acetate Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Icatibant Acetate Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Icatibant Acetate Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Icatibant Acetate Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Icatibant Acetate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Icatibant Acetate Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Icatibant Acetate Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Icatibant Acetate Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Icatibant Acetate Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Icatibant Acetate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Icatibant Acetate Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Icatibant Acetate Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Icatibant Acetate Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Icatibant Acetate Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Icatibant Acetate Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Icatibant Acetate Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Icatibant Acetate Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Icatibant Acetate Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Icatibant Acetate Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Icatibant Acetate Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Icatibant Acetate Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Icatibant Acetate Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Icatibant Acetate Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Icatibant Acetate Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Icatibant Acetate Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Cipla Company Information Table 72. Cipla Business Overview Table 73. Cipla Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Cipla Icatibant Acetate Injection Product Portfolio Table 75. Cipla Recent Development Table 76. Eugia Pharma Specialities Company Information Table 77. Eugia Pharma Specialities Business Overview Table 78. Eugia Pharma Specialities Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Eugia Pharma Specialities Icatibant Acetate Injection Product Portfolio Table 80. Eugia Pharma Specialities Recent Development Table 81. Fresenius Kabi Company Information Table 82. Fresenius Kabi Business Overview Table 83. Fresenius Kabi Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Fresenius Kabi Icatibant Acetate Injection Product Portfolio Table 85. Fresenius Kabi Recent Development Table 86. Glenmark Pharmaceuticals Company Information Table 87. Glenmark Pharmaceuticals Business Overview Table 88. Glenmark Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Glenmark Pharmaceuticals Icatibant Acetate Injection Product Portfolio Table 90. Glenmark Pharmaceuticals Recent Development Table 91. Chengdu Shengnuo Biology Pharmacy Company Information Table 92. Chengdu Shengnuo Biology Pharmacy Business Overview Table 93. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product Portfolio Table 95. Chengdu Shengnuo Biology Pharmacy Recent Development Table 96. Jiangsu Hengrui Pharmaceuticals Company Information Table 97. Jiangsu Hengrui Pharmaceuticals Business Overview Table 98. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product Portfolio Table 100. Jiangsu Hengrui Pharmaceuticals Recent Development Table 101. Sandoz Company Information Table 102. Sandoz Business Overview Table 103. Sandoz Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sandoz Icatibant Acetate Injection Product Portfolio Table 105. Sandoz Recent Development Table 106. Takeda Pharmaceuticals Company Information Table 107. Takeda Pharmaceuticals Business Overview Table 108. Takeda Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Takeda Pharmaceuticals Icatibant Acetate Injection Product Portfolio Table 110. Takeda Pharmaceuticals Recent Development Table 111. North America Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units) Table 113. North America Icatibant Acetate Injection Sales Market Share by Country (2021-2026) Table 114. North America Icatibant Acetate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Icatibant Acetate Injection Sales Market Share Forecast by Country (2027-2032) Table 116. North America Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Icatibant Acetate Injection Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Icatibant Acetate Injection Market Share by Country (2021-2026) Table 119. North America Icatibant Acetate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Icatibant Acetate Injection Market Share Forecast by Country (2027-2032) Table 121. Europe Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units) Table 123. Europe Icatibant Acetate Injection Sales Market Share by Country (2021-2026) Table 124. Europe Icatibant Acetate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Icatibant Acetate Injection Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Icatibant Acetate Injection Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Icatibant Acetate Injection Market Share by Country (2021-2026) Table 129. Europe Icatibant Acetate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Icatibant Acetate Injection Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Icatibant Acetate Injection Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Icatibant Acetate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Icatibant Acetate Injection Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Icatibant Acetate Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Icatibant Acetate Injection Market Share by Country (2021-2026) Table 139. Asia-Pacific Icatibant Acetate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Icatibant Acetate Injection Market Share Forecast by Country (2027-2032) Table 141. Latin America Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units) Table 143. Latin America Icatibant Acetate Injection Sales Market Share by Country (2021-2026) Table 144. Latin America Icatibant Acetate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Icatibant Acetate Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Icatibant Acetate Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Icatibant Acetate Injection Market Share by Country (2021-2026) Table 149. Latin America Icatibant Acetate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Icatibant Acetate Injection Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Icatibant Acetate Injection Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Icatibant Acetate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Icatibant Acetate Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Icatibant Acetate Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Icatibant Acetate Injection Market Share by Country (2021-2026) Table 159. Middle East and Africa Icatibant Acetate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Icatibant Acetate Injection Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Icatibant Acetate Injection Distributors List Table 164. Icatibant Acetate Injection Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Icatibant Acetate Injection Image Figure 2. Global Icatibant Acetate Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Icatibant Acetate Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Icatibant Acetate Injection Sales (2021-2032) & (K Units) Figure 5. Original Drug Image Figure 6. Global Original Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drug Image Figure 8. Global Generic Drug Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Icatibant Acetate Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Icatibant Acetate Injection Market Share by Type 2025 VS 2032 Figure 11. North America Icatibant Acetate Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Icatibant Acetate Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Icatibant Acetate Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Icatibant Acetate Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Icatibant Acetate Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Icatibant Acetate Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Icatibant Acetate Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Icatibant Acetate Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Icatibant Acetate Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Icatibant Acetate Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Icatibant Acetate Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Icatibant Acetate Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Icatibant Acetate Injection Market Share by Application 2025 VS 2032 Figure 31. North America Icatibant Acetate Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Icatibant Acetate Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Icatibant Acetate Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Icatibant Acetate Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Icatibant Acetate Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Icatibant Acetate Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Icatibant Acetate Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Icatibant Acetate Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Icatibant Acetate Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Icatibant Acetate Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Icatibant Acetate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Icatibant Acetate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Icatibant Acetate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Icatibant Acetate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Icatibant Acetate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Icatibant Acetate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Icatibant Acetate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Icatibant Acetate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Icatibant Acetate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Icatibant Acetate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Icatibant Acetate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Icatibant Acetate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Icatibant Acetate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Icatibant Acetate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Icatibant Acetate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Icatibant Acetate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Icatibant Acetate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Icatibant Acetate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Icatibant Acetate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Icatibant Acetate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Icatibant Acetate Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Icatibant Acetate Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Cipla
  • Eugia Pharma Specialities
  • Fresenius Kabi
  • Glenmark Pharmaceuticals
  • Chengdu Shengnuo Biology Pharmacy
  • Jiangsu Hengrui Pharmaceuticals
  • Sandoz
  • Takeda Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Icatibant Acetate Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Icatibant Acetate Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Icatibant Acetate Injection Market by Type
  6. 1.3.1 Original Drug
  7. 1.3.2 Generic Drug
  8. 1.4 Global Icatibant Acetate Injection Market Size by Type
  9. 1.4.1 Global Icatibant Acetate Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Icatibant Acetate Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Icatibant Acetate Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Icatibant Acetate Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Icatibant Acetate Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Icatibant Acetate Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Icatibant Acetate Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Icatibant Acetate Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Icatibant Acetate Injection Industry Trends
  2. 2.2 Icatibant Acetate Injection Industry Drivers
  3. 2.3 Icatibant Acetate Injection Industry Opportunities and Challenges
  4. 2.4 Icatibant Acetate Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Icatibant Acetate Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Icatibant Acetate Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Icatibant Acetate Injection Price (2021-2026)
  4. 3.4 Global Icatibant Acetate Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Icatibant Acetate Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Icatibant Acetate Injection Company, Product Type & Application
  7. 3.7 Global Icatibant Acetate Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Icatibant Acetate Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Icatibant Acetate Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Icatibant Acetate Injection Tier 1, Tier 2, and Tier 3
4 Icatibant Acetate Injection Regional Status and Outlook
  1. 4.1 Global Icatibant Acetate Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Icatibant Acetate Injection Historic Market Size by Region
  3. 4.2.1 Global Icatibant Acetate Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Icatibant Acetate Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Icatibant Acetate Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Icatibant Acetate Injection Forecasted Market Size by Region
  7. 4.3.1 Global Icatibant Acetate Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Icatibant Acetate Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Icatibant Acetate Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Icatibant Acetate Injection by Application
  1. 5.1 Icatibant Acetate Injection Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Icatibant Acetate Injection Market Size by Application
  6. 5.2.1 Global Icatibant Acetate Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Icatibant Acetate Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Icatibant Acetate Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Icatibant Acetate Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Icatibant Acetate Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Icatibant Acetate Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Icatibant Acetate Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Icatibant Acetate Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cipla
  2. 6.1.1 Cipla Company Information
  3. 6.1.2 Cipla Business Overview
  4. 6.1.3 Cipla Icatibant Acetate Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cipla Icatibant Acetate Injection Product Portfolio
  6. 6.1.5 Cipla Recent Developments
  7. 6.2 Eugia Pharma Specialities
  8. 6.2.1 Eugia Pharma Specialities Company Information
  9. 6.2.2 Eugia Pharma Specialities Business Overview
  10. 6.2.3 Eugia Pharma Specialities Icatibant Acetate Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eugia Pharma Specialities Icatibant Acetate Injection Product Portfolio
  12. 6.2.5 Eugia Pharma Specialities Recent Developments
  13. 6.3 Fresenius Kabi
  14. 6.3.1 Fresenius Kabi Company Information
  15. 6.3.2 Fresenius Kabi Business Overview
  16. 6.3.3 Fresenius Kabi Icatibant Acetate Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fresenius Kabi Icatibant Acetate Injection Product Portfolio
  18. 6.3.5 Fresenius Kabi Recent Developments
  19. 6.4 Glenmark Pharmaceuticals
  20. 6.4.1 Glenmark Pharmaceuticals Company Information
  21. 6.4.2 Glenmark Pharmaceuticals Business Overview
  22. 6.4.3 Glenmark Pharmaceuticals Icatibant Acetate Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Glenmark Pharmaceuticals Icatibant Acetate Injection Product Portfolio
  24. 6.4.5 Glenmark Pharmaceuticals Recent Developments
  25. 6.5 Chengdu Shengnuo Biology Pharmacy
  26. 6.5.1 Chengdu Shengnuo Biology Pharmacy Company Information
  27. 6.5.2 Chengdu Shengnuo Biology Pharmacy Business Overview
  28. 6.5.3 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product Portfolio
  30. 6.5.5 Chengdu Shengnuo Biology Pharmacy Recent Developments
  31. 6.6 Jiangsu Hengrui Pharmaceuticals
  32. 6.6.1 Jiangsu Hengrui Pharmaceuticals Company Information
  33. 6.6.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  34. 6.6.3 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product Portfolio
  36. 6.6.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  37. 6.7 Sandoz
  38. 6.7.1 Sandoz Company Information
  39. 6.7.2 Sandoz Business Overview
  40. 6.7.3 Sandoz Icatibant Acetate Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sandoz Icatibant Acetate Injection Product Portfolio
  42. 6.7.5 Sandoz Recent Developments
  43. 6.8 Takeda Pharmaceuticals
  44. 6.8.1 Takeda Pharmaceuticals Company Information
  45. 6.8.2 Takeda Pharmaceuticals Business Overview
  46. 6.8.3 Takeda Pharmaceuticals Icatibant Acetate Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Takeda Pharmaceuticals Icatibant Acetate Injection Product Portfolio
  48. 6.8.5 Takeda Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Icatibant Acetate Injection Sales by Country
  2. 7.1.1 North America Icatibant Acetate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Icatibant Acetate Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Icatibant Acetate Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Icatibant Acetate Injection Market Size by Country
  6. 7.2.1 North America Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Icatibant Acetate Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Icatibant Acetate Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Icatibant Acetate Injection Sales by Country
  2. 8.1.1 Europe Icatibant Acetate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Icatibant Acetate Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Icatibant Acetate Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Icatibant Acetate Injection Market Size by Country
  6. 8.2.1 Europe Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Icatibant Acetate Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Icatibant Acetate Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Icatibant Acetate Injection Sales by Country
  2. 9.1.1 Asia-Pacific Icatibant Acetate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Icatibant Acetate Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Icatibant Acetate Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Icatibant Acetate Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Icatibant Acetate Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Icatibant Acetate Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Icatibant Acetate Injection Sales by Country
  2. 10.1.1 South America Icatibant Acetate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Icatibant Acetate Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Icatibant Acetate Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Icatibant Acetate Injection Market Size by Country
  6. 10.2.1 South America Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Icatibant Acetate Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Icatibant Acetate Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Icatibant Acetate Injection Sales by Country
  2. 11.1.1 Middle East and Africa Icatibant Acetate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Icatibant Acetate Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Icatibant Acetate Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Icatibant Acetate Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Icatibant Acetate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Icatibant Acetate Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Icatibant Acetate Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Icatibant Acetate Injection Value Chain Analysis
  2. 12.1.1 Icatibant Acetate Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Icatibant Acetate Injection Production Mode & Process
  7. 12.2 Icatibant Acetate Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Icatibant Acetate Injection Distributors
  10. 12.2.3 Icatibant Acetate Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst